Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Preliminary clinical data support the use of vaginal diazepam

March 5, 2010

Rexahn submits protocol of phase IIb Zoraxel trial in erectile dysfunction to FDA

March 5, 2010

Antares completes enrollment in phase III Anturol trial in overactive bladder

March 3, 2010

Global Health Ventures to begin European trials of X-Excite for erectile dysfunction

March 1, 2010

Astellas withdraws application in Japan for Micardis in type 2 diabetic incipient nephropathy

Feb. 26, 2010

Nymox provides update on pivotal phase III NX-1207 trials for BPH

Feb. 12, 2010

FYO-750 improves bladder capacity in neurogenic detrusor overactivity in rats

Feb. 11, 2010

3SBio and Panacor sign agreement to develop and commercialize Nephoxil in China

Feb. 11, 2010

Palatin Technologies doses first male cohort in bremelanotide safety trial

Feb. 10, 2010

European Commission grants marketing authorization for silodosin in BPH

Feb. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...